PMID: 8456419Feb 1, 1993Paper

Cost-benefit relationship of serologic studies in autoimmune diseases

Therapeutische Umschau. Revue thérapeutique
P J GrobR W Dubs

Abstract

Autoimmune disorders are mainly clinically defined disease entities. The diagnosis of many of the systemic autoimmunopathies is based on characteristic combinations of symptoms, some of them overlapping various kinds and being of unspecific nature. Therefore, laboratory parameters such as autoantibodies, components of the complement system, some cytokines and their receptors, etc., are used for the diagnosis, although many of them are of limited specificity and sensitivity. The most important immunoparameters being of value for diagnosis and disease monitoring are discussed, and a stepwise procedure is proposed in order to reduce the costs. Basis are the screening tests for antinuclear antibodies (ANA) and for antibodies against cytoplasmatic components of granulocytes (ANCA). Depending on more specific questions, other tests and test combinations are then applied in second and third priorities.

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Revue médicale suisse
Stéphanie PetitpierrePierre-Alexandre Bart
Clinical Rheumatology
Fernando Luiz Barros EdingtonMittermayer Barreto Santiago
Advances in Experimental Medicine and Biology
M Waldendorf, M Schneider
© 2021 Meta ULC. All rights reserved